Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$19.54
+8.5%
$17.45
$8.92
$24.50
$885.16M1.69425,890 shs1.69 million shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$3.07
-6.1%
$2.50
$1.92
$24.13
$158.73M1.851.23 million shs1.43 million shs
ViewRay, Inc. stock logo
VRAY
ViewRay
$0.34
$0.02
$4.96
$4.59M0.817.51 million shs108.50 million shs
Zynex, Inc. stock logo
ZYXI
Zynex
$10.49
+1.5%
$12.01
$6.88
$13.77
$333.27M0.49224,512 shs162,008 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+0.39%-0.83%-0.83%-3.43%-3.22%
Outset Medical, Inc. stock logo
OM
Outset Medical
-20.82%+9.00%+30.28%-4.11%-84.35%
ViewRay, Inc. stock logo
VRAY
ViewRay
0.00%0.00%0.00%0.00%-97.50%
Zynex, Inc. stock logo
ZYXI
Zynex
-3.63%-10.40%-15.80%-16.75%+7.60%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
1.2171 of 5 stars
2.51.00.00.03.02.50.6
Outset Medical, Inc. stock logo
OM
Outset Medical
0.8275 of 5 stars
3.21.00.00.01.00.80.6
ViewRay, Inc. stock logo
VRAY
ViewRay
1.7139 of 5 stars
3.00.00.04.40.01.70.0
Zynex, Inc. stock logo
ZYXI
Zynex
3.1128 of 5 stars
3.50.00.00.02.51.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
3.00
Buy$23.4019.75% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
2.33
Hold$5.4276.44% Upside
ViewRay, Inc. stock logo
VRAY
ViewRay
2.00
Hold$1.00∞ Upside
Zynex, Inc. stock logo
ZYXI
Zynex
3.00
Buy$18.0071.59% Upside

Current Analyst Ratings

Latest BLFS, VRAY, OM, and ZYXI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2024
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$21.00
4/8/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
4/5/2024
Outset Medical, Inc. stock logo
OM
Outset Medical
CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$6.00
4/4/2024
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$22.00
3/1/2024
Zynex, Inc. stock logo
ZYXI
Zynex
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$13.00 ➝ $15.00
3/1/2024
Zynex, Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $21.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$143.27M6.18N/AN/A$7.67 per share2.55
Outset Medical, Inc. stock logo
OM
Outset Medical
$130.38M1.22N/AN/A$2.45 per share1.25
ViewRay, Inc. stock logo
VRAY
ViewRay
$105.86M0.00N/AN/A$0.45 per share0.00
Zynex, Inc. stock logo
ZYXI
Zynex
$184.32M1.81$0.40 per share26.10$1.04 per share10.09

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$66.43M-$1.52N/AN/AN/A-46.37%-13.36%-10.83%8/13/2024 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$172.80M-$3.38N/AN/AN/A-132.54%-102.50%-52.42%8/7/2024 (Estimated)
ViewRay, Inc. stock logo
VRAY
ViewRay
-$107.33M-$0.60N/AN/AN/A-104.30%-120.48%-42.39%N/A
Zynex, Inc. stock logo
ZYXI
Zynex
$9.73M$0.2345.6111.16N/A4.33%16.34%5.76%N/A

Latest BLFS, VRAY, OM, and ZYXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024Q1 2024
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.25-$0.19+$0.06-$0.16$29.30 million$31.73 million  
2/29/2024Q4 2023
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$0.24-$0.22+$0.02-$0.14$32.70 million$32.73 million
2/29/2024Q4 2023
Zynex, Inc. stock logo
ZYXI
Zynex
$0.17$0.04-$0.13$0.04$54.53 million$47.28 million    
2/21/2024Q4 2023
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.74-$0.77-$0.03-$0.77$30.40 million$30.51 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
ViewRay, Inc. stock logo
VRAY
ViewRay
N/AN/AN/AN/AN/A
Zynex, Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
0.06
2.86
1.83
Outset Medical, Inc. stock logo
OM
Outset Medical
1.06
5.26
4.37
ViewRay, Inc. stock logo
VRAY
ViewRay
N/A
1.16
0.91
Zynex, Inc. stock logo
ZYXI
Zynex
1.76
3.58
2.87

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
ViewRay, Inc. stock logo
VRAY
ViewRay
92.97%
Zynex, Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.70%
Outset Medical, Inc. stock logo
OM
Outset Medical
3.50%
ViewRay, Inc. stock logo
VRAY
ViewRay
2.50%
Zynex, Inc. stock logo
ZYXI
Zynex
52.13%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
40945.30 million44.08 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
48051.70 million49.89 millionNot Optionable
ViewRay, Inc. stock logo
VRAY
ViewRay
295183.40 million178.82 millionOptionable
Zynex, Inc. stock logo
ZYXI
Zynex
1,10031.77 million15.21 millionOptionable

BLFS, VRAY, OM, and ZYXI Headlines

SourceHeadline
Heres Why We Think Zynex, Inc.s (NASDAQ:ZYXI) CEO Compensation Looks FairHere's Why We Think Zynex, Inc.'s (NASDAQ:ZYXI) CEO Compensation Looks Fair
finance.yahoo.com - May 10 at 8:07 AM
LSV Asset Management Makes New $818,000 Investment in Zynex, Inc. (NASDAQ:ZYXI)LSV Asset Management Makes New $818,000 Investment in Zynex, Inc. (NASDAQ:ZYXI)
marketbeat.com - May 10 at 7:02 AM
Are Investors Undervaluing Zynex (ZYXI) Right Now?Are Investors Undervaluing Zynex (ZYXI) Right Now?
zacks.com - May 9 at 10:46 AM
Zynex to Present at the RBC Capital Markets Global Healthcare ConferenceZynex to Present at the RBC Capital Markets Global Healthcare Conference
prnewswire.com - May 9 at 9:15 AM
3 Reasons Growth Investors Will Love Zynex (ZYXI)3 Reasons Growth Investors Will Love Zynex (ZYXI)
zacks.com - May 7 at 1:46 PM
Zynex Executives Recognized Among Top 25 in Medical TechnologyZynex Executives Recognized Among Top 25 in Medical Technology
prnewswire.com - May 7 at 9:15 AM
Q3 2024 Earnings Forecast for Zynex, Inc. (NASDAQ:ZYXI) Issued By HC WainwrightQ3 2024 Earnings Forecast for Zynex, Inc. (NASDAQ:ZYXI) Issued By HC Wainwright
americanbankingnews.com - May 4 at 4:16 AM
Zynex, Inc. (NASDAQ:ZYXI) to Post Q3 2024 Earnings of $0.16 Per Share, HC Wainwright ForecastsZynex, Inc. (NASDAQ:ZYXI) to Post Q3 2024 Earnings of $0.16 Per Share, HC Wainwright Forecasts
marketbeat.com - May 3 at 8:40 AM
Zynex (NASDAQ:ZYXI) Rating Reiterated by HC WainwrightZynex (NASDAQ:ZYXI) Rating Reiterated by HC Wainwright
americanbankingnews.com - May 3 at 5:10 AM
Zynex, Inc. to Post Q2 2024 Earnings of $0.08 Per Share, HC Wainwright Forecasts (NASDAQ:ZYXI)Zynex, Inc. to Post Q2 2024 Earnings of $0.08 Per Share, HC Wainwright Forecasts (NASDAQ:ZYXI)
americanbankingnews.com - May 3 at 1:58 AM
Zynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call TranscriptZynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 2 at 9:56 AM
Q2 2024 EPS Estimates for Zynex, Inc. (NASDAQ:ZYXI) Decreased by AnalystQ2 2024 EPS Estimates for Zynex, Inc. (NASDAQ:ZYXI) Decreased by Analyst
marketbeat.com - May 2 at 7:34 AM
Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ...Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ...
finance.yahoo.com - May 2 at 7:32 AM
ZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024ZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024
msn.com - April 30 at 9:54 PM
Zynex (NASDAQ:ZYXI) Updates Q2 2024 Earnings GuidanceZynex (NASDAQ:ZYXI) Updates Q2 2024 Earnings Guidance
marketbeat.com - April 30 at 8:14 PM
Zynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls ShortZynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls Short
finance.yahoo.com - April 30 at 6:11 PM
Zynex Reports First Quarter 2024 Financial ResultsZynex Reports First Quarter 2024 Financial Results
prnewswire.com - April 30 at 4:01 PM
What Wall Street expects from Zynexs earningsWhat Wall Street expects from Zynex's earnings
markets.businessinsider.com - April 29 at 10:18 AM
Zynex, Inc. (ZYXI)Zynex, Inc. (ZYXI)
finance.yahoo.com - April 28 at 8:31 PM
Investing in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gainInvesting in Zynex (NASDAQ:ZYXI) five years ago would have delivered you a 82% gain
finance.yahoo.com - April 26 at 1:27 PM
Zynex Sets First Quarter 2024 Earnings CallZynex Sets First Quarter 2024 Earnings Call
prnewswire.com - April 18 at 9:15 AM
3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation?
investorplace.com - April 2 at 2:58 PM
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition AwardZynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award
prnewswire.com - April 2 at 9:15 AM
With 51% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot riding on the companys futureWith 51% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot riding on the company's future
finance.yahoo.com - March 30 at 11:16 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

BioLife Solutions logo

BioLife Solutions

NASDAQ:BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Outset Medical logo

Outset Medical

NASDAQ:OM
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
ViewRay logo

ViewRay

NASDAQ:VRAY
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.
Zynex logo

Zynex

NASDAQ:ZYXI
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.